Pertuzumab 420 mg/14 mL Suppliers & Bulk Manufacturers

Available Forms: Solution for IV infusion

Available Strengths: 420 mg/14 mL

Reference Brands: Perjeta (USA/EU), Pertuza (India), Herticad (India)

Category: Oncology Cancer Care

Pertuzumab is a Oncology Cancer Care product available as Solution for IV infusion in strengths 420 mg/14 mL. It corresponds to the reference brands Perjeta (USA/EU), Pertuza (India), Herticad (India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Pertuzumab is a monoclonal antibody used in the treatment of HER2-positive breast cancer, a type of cancer that produces higher levels of the human epidermal growth factor receptor 2 (HER2) protein. This protein promotes the growth and spread of cancer cells. Pertuzumab works by specifically targeting the HER2 receptor and blocking signals that stimulate tumor cell growth. By interfering with these signaling pathways, the medicine helps slow down or stop the progression of cancer.

Pertuzumab is commonly used in combination with other cancer treatments, particularly trastuzumab and the chemotherapy drug docetaxel. This combination therapy is widely used for patients with metastatic HER2-positive breast cancer, where the disease has spread to other parts of the body. In addition to treating advanced disease, pertuzumab is also used as a neoadjuvant treatment in early HER2-positive breast cancer. In this setting, it is given before surgery to help shrink tumors and improve treatment outcomes.

As a targeted biological therapy, pertuzumab plays an important role in modern oncology by providing a more precise treatment approach for patients whose tumors overexpress the HER2 protein. Its use in combination regimens has significantly improved clinical outcomes for many patients with HER2-positive breast cancer.